Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Femasys Inc. - Common Stock (NQ:FEMY)

0.3530 -0.0183 (-4.93%)
Streaming Delayed Price Updated: 11:33 AM EDT, Jun 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Femasys Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. 
Via Benzinga
News headline image
What's Going On Femasys Shares Today? ↗
Femasys Inc (NASDAQ: FEMY) shares are trading higher after the company announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for  
Via Benzinga
News headline image
Chardan Capital Maintains Buy Rating for Femasys: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Femasys's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Thursday. Following the market opening Thursday, the Dow traded up 0.15% to 35,573.49 while the NASDAQ... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Tivic Health Systems Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket ↗
Gainers Nanobiotix S.A. (NASDAQ: NBTX) shares surged 59.3% to $8.02 in pre-market trading after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Femasys Shares Are On The Move Monday ↗
Femasys Inc (NASDAQ: FEMY) shares are trading higher Monday after the company announced that it received an Investigational Device Exemption (IDE) approval from the FDA to evaluate FemBloc 
Via Benzinga
News headline image
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Femasys Announces FDA Approval of its IDE for the Pivotal Clinical Trial of FemBloc Permanent Birth Control, a Non-Surgical Alternative for Women
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Inc. Replaces Two Board Members with Seasoned Industry Leaders in the Life Sciences
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys’ FemCath Intrauterine Catheter Receives Product Approval in Canada
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Inc. Announces Financial Results for the First Quarter Ended March 31, 2023
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys’ FemCerv Endocervical Tissue Sampler for Cervical Cancer Diagnosis Receives Product Approval in Canada
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Inc. to Showcase FemCerv at the Annual Meeting for the American Society for Colposcopy and Cervical Pathology
From Femasys Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results ↗
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. 
Via Benzinga
News headline image
Femasys Announces $3.9 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys’ FemaSeed Localized Directional Insemination for Infertility Receives Product Approval in Canada
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Inc. Announces Financial Results for the Year Ended December 31, 2022 and Provides Corporate Update
From Femasys Inc.
Via GlobeNewswire
News headline image
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.